{
    "clinical_study": {
        "@rank": "38730", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Matching placebo 120 mg TID x 6 months plus a behavioral weight loss program"
            }, 
            {
                "arm_group_label": "Orlistat", 
                "arm_group_type": "Experimental", 
                "description": "Orlistat 120 mg TID for 6 months plus a behavioral weight loss program"
            }
        ], 
        "brief_summary": {
            "textblock": "Obesity is a condition affecting one-third off the U.S. population and is a major risk actor\n      for the development of Type 2 diabetes, hyperlipidemia (increased levels of fat in the\n      blood), hypertension (high blood pressure), and other disorders of the heart and lungs.\n      Individuals with the onset of obesity during childhood or adolescence are at an increased\n      risk of obesity-related, diseases, both during adolescence and later in adult life.\n\n      African American girls and women are at an increased risk for obesity, and have substantial\n      rates of obesity-related diseases and causes of death.  Further, many African American adult\n      women fail to respond to many  of the therapeutic approaches used to treat obesity.  At\n      present there are no medical therapies proven effective for the correction of severe obesity\n      in children or adolescents.\n\n      One medication that may have a favorable risk-benefit ratio in pediatric populations is\n      Orlistat (Xenical, Hoffmann LaRoche).  Orlistat works by preventing the action of enzymes in\n      the digestive process, interfering with the absorption of approximately 1/3 of the fat eaten\n      in the diet.  Xenical appears to be effective for reducing weight and obesity-associated\n      diseases in obese adults.\n\n      Researchers propose to determine the safety, tolerability, and efficacy of Xenical in 12-17\n      year old severely obese African American and Caucasian children and adolescents who have one\n      or more obesity-related disease (hypertension, hyperlipidemia, sleep apnea, hepatic\n      steatosis, insulin resistance, impaired glucose tolerance, or Type 2 diabetes)."
        }, 
        "brief_title": "Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "Orlistat 120 mg TID for 6 months plus a behavioral weight loss program\nOrlistat : Subjects receive drug for 6 months plus a 12 week intensive behavioral weight los program. Subjects return for monthly visits for 3 more months.", 
                            "title": "Orlistat"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "Matching placebo 120 mg TID x 6 months plus a behavioral weight loss program\nPlacebo : Subjects receive drug for 6 months plus a 12 week intensive behavioral weight los program. Subjects return for monthly visits for 3 more months.", 
                            "title": "Placebo"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "100"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "100"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "200"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "100"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "100"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "200"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "<=18 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "0"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "0"
                                                }
                                            ]
                                        }, 
                                        "sub_title": ">=65 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "1.38", 
                                                "@value": "14.65"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "1.46", 
                                                "@value": "14.52"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "1.41", 
                                                "@value": "14.59"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "65"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "66"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "131"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "35"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "34"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "69"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "100"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "100"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "200"
                                            }
                                        ]
                                    }, 
                                    "sub_title": "United States"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.", 
                "restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed."
            }, 
            "limitations_and_caveats": "None", 
            "outcome_list": {
                "outcome": [
                    {
                        "analysis_list": {
                            "analysis": {
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "method": "ANCOVA", 
                                "non_inferiority": "No", 
                                "p_value": "0.007"
                            }
                        }, 
                        "description": "Body Mass index standard deviation score calculated for age and sex according to Centers for Disease Control standards. See:  Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 2002; (246): 1-190.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Orlistat 120 mg TID for 6 months plus a behavioral weight loss program\nOrlistat : Subjects receive drug for 6 months plus a 12 week intensive behavioral weight los program. Subjects return for monthly visits for 3 more months.", 
                                    "title": "Orlistat"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Matching placebo 120 mg TID x 6 months plus a behavioral weight loss program\nPlacebo : Subjects receive drug for 6 months plus a 12 week intensive behavioral weight los program. Subjects return for monthly visits for 3 more months.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "100"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "100"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.02", 
                                                        "@value": "-0.12"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "0.02", 
                                                        "@value": "-0.06"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Body Mass index standard deviation score calculated for age and sex according to Centers for Disease Control standards. See:  Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 2002; (246): 1-190.", 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Change in BMI Standard Deviation Score", 
                                    "units": "Standard Deviation Score"
                                }
                            ]
                        }, 
                        "population": "Multiple imputation analysis", 
                        "safety_issue": "No", 
                        "time_frame": "baseline to 6 months", 
                        "title": "Change in BMI Standard Deviation Score", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Weight in kg", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Orlistat 120 mg TID for 6 months plus a behavioral weight loss program\nOrlistat : Subjects receive drug for 6 months plus a 12 week intensive behavioral weight los program. Subjects return for monthly visits for 3 more months.", 
                                    "title": "Orlistat"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Matching placebo 120 mg TID x 6 months plus a behavioral weight loss program\nPlacebo : Subjects receive drug for 6 months plus a 12 week intensive behavioral weight los program. Subjects return for monthly visits for 3 more months.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "100"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "100"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.7", 
                                                        "@value": "-2.9"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "0.7", 
                                                        "@value": "-0.6"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Weight in kg", 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Change in Body Weight", 
                                    "units": "kg"
                                }
                            ]
                        }, 
                        "population": "Multiple imputation analysis", 
                        "safety_issue": "No", 
                        "time_frame": "baseline to 6 months", 
                        "title": "Change in Body Weight", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "BMI is calculated in kg/m2.  Change from baseline to 6 months of treatment", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Orlistat 120 mg TID for 6 months plus a behavioral weight loss program\nOrlistat : Subjects receive drug for 6 months plus a 12 week intensive behavioral weight los program. Subjects return for monthly visits for 3 more months.", 
                                    "title": "Orlistat"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Matching placebo 120 mg TID x 6 months plus a behavioral weight loss program\nPlacebo : Subjects receive drug for 6 months plus a 12 week intensive behavioral weight los program. Subjects return for monthly visits for 3 more months.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "100"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "100"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.26", 
                                                        "@value": "-1.44"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "0.20", 
                                                        "@value": "-0.50"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "BMI is calculated in kg/m2.  Change from baseline to 6 months of treatment", 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Change in Body Mass Index", 
                                    "units": "kg per square meter"
                                }
                            ]
                        }, 
                        "population": "Muliple imputation analysis", 
                        "safety_issue": "No", 
                        "time_frame": "baseline to 6 months", 
                        "title": "Change in Body Mass Index", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "body fat distribution measures obtained from Dual-energy X-ray Absorptiometry (DEXA)", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Orlistat 120 mg TID for 6 months plus a behavioral weight loss program\nOrlistat : Subjects receive drug for 6 months plus a 12 week intensive behavioral weight los program. Subjects return for monthly visits for 3 more months.", 
                                    "title": "Orlistat"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Matching placebo 120 mg TID x 6 months plus a behavioral weight loss program\nPlacebo : Subjects receive drug for 6 months plus a 12 week intensive behavioral weight los program. Subjects return for monthly visits for 3 more months.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "100"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "100"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.55", 
                                                        "@value": "-3.2"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "0.53", 
                                                        "@value": "-1.7"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "body fat distribution measures obtained from Dual-energy X-ray Absorptiometry (DEXA)", 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Change in Body Fat (kg)", 
                                    "units": "kg"
                                }
                            ]
                        }, 
                        "population": "Multiple Imputation analysis", 
                        "safety_issue": "No", 
                        "time_frame": "baseline to 6 months", 
                        "title": "Change in Body Fat (kg)", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Difference in change of weight in kg according to race (Non-Hispanic White versus Non-Hispanic Black)", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Change in weight for Non-Hispanic Black participants treated with orlistat", 
                                    "title": "Orlistat - Non-Hispanic Blacks"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Change in weight for Non-Hispanic White participants treated with orlistat", 
                                    "title": "Orlistat - Non- Hispanic Whites"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Change in weight for Non-Hispanic Black participants treated with placebo", 
                                    "title": "Placebo - Non-Hispanic Blacks"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "Change in weight for Non-Hispanic White participants treated with placebo", 
                                    "title": "Placebo - Non-Hispanic Whites"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "63"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "37"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "60"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "40"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.812", 
                                                        "@value": "-2.126"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "1.046", 
                                                        "@value": "-3.742"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "0.835", 
                                                        "@value": "0.415"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@spread": "1.013", 
                                                        "@value": "-1.580"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Difference in change of weight in kg according to race (Non-Hispanic White versus Non-Hispanic Black)", 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Effect of Race on Change in Weight (kg)", 
                                    "units": "kg"
                                }
                            ]
                        }, 
                        "population": "Multiple imputation analysis", 
                        "safety_issue": "No", 
                        "time_frame": "baseline to 6 months", 
                        "title": "Effect of Race on Change in Weight (kg)", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "Orlistat 120 mg TID for 6 months plus a behavioral weight loss program\nOrlistat : Subjects receive drug for 6 months plus a 12 week intensive behavioral weight los program. Subjects return for monthly visits for 3 more months.", 
                            "title": "Orlistat"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "Matching placebo 120 mg TID x 6 months plus a behavioral weight loss program\nPlacebo : Subjects receive drug for 6 months plus a 12 week intensive behavioral weight los program. Subjects return for monthly visits for 3 more months.", 
                            "title": "Placebo"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "drop_withdraw_reason_list": {
                            "drop_withdraw_reason": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "6", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "7", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "Lack of Efficacy"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "4", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "5", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "Lack of family interest"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "2", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "2", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "Lost to Follow-up"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "1", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "2", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "medication intolerance"
                                }
                            ]
                        }, 
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "100", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "100", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "87", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "84", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "13", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "16", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "pre_assignment_details": "Most subjects screened but not enrolled (101) did not have an obesity-related comorbid condition (i.e., hypertension or dyslipidemia). 16 met a medical exclusion, and 13 declined participation after undergoing initial evaluation.", 
                "recruitment_details": "Accrual for RCT began in 1999 and ended in 2008. All subjects were screened at the NIH Clinical Center."
            }, 
            "point_of_contact": {
                "email": "yanovskj@mail.nih.gov", 
                "name_or_title": "Jack A. Yanovski, MD, PhD, Chief SGO, PDEGEN", 
                "organization": "National Institute of Child Health and Human Development, NIH", 
                "phone": "301-496-4686"
            }, 
            "reported_events": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "Orlistat 120 mg TID for 6 months plus a behavioral weight loss program Orlistat : Subjects receive drug for 6 months plus a 12 week intensive behavioral weight los program. Subjects return for monthly visits for 3 more months.", 
                            "title": "Orlistat"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "Matching placebo 120 mg TID x 6 months plus a behavioral weight loss program Placebo : Subjects receive drug for 6 months plus a 12 week intensive behavioral weight los program. Subjects return for monthly visits for 3 more months.", 
                            "title": "Placebo"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "95", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "94", 
                                                "@subjects_at_risk": "100"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "7", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "7", 
                                                "@subjects_at_risk": "100"
                                            }
                                        ], 
                                        "sub_title": "ear disorders (otitis, earache, ear pain)"
                                    }
                                }, 
                                "title": "Ear and labyrinth disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "8", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "9", 
                                                "@subjects_at_risk": "100"
                                            }
                                        ], 
                                        "sub_title": "eye disorders (change in vision, conjunctivitis, styes)"
                                    }
                                }, 
                                "title": "Eye disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "16", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "21", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "abdominal pain or cramping"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "18", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "bloating or gas"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "BORBORYGMI"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "constipation"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "56", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "11", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "Controlled discharge of oil without stool"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "25", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "22", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "Decreased frequency of bowel movements"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "21", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "diarrhea"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "61", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "fatty-appearing stools"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "60", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "47", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "flatulence (passage of gas)"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "43", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "11", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "flatus with discharge"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "19", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "frequent urge for bowel movement"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "hiccups"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "68", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "45", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "Increased frequency of bowel movements"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "NAUSEA"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "oily spotting"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "rectal bleeding - hemorrhoids"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "68", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "42", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "soft or deliquescent stools"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "stomach pain or cramps"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "64", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "34", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "Stools almost all liquid with very few solid parts"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "11", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "Stools hard and in the shape of small pellets"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "83", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "18", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "Stools mixed with fat or with a separate oily layer"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "60", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "11", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "uncontrolled passage of stool or oil"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "44", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "18", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "Urgent, but controlled, need to produce stools"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "Vomiting"
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "dizziness"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "epistaxis"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "feeling cold"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "14", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "17", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "headache"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "increased sweating"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "increased thirst"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "sinusitis, post-nasal drip or nasal stuffiness"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "unusual tiredness or weakness (fatigue)"
                                        }
                                    ]
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "12", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "Pharyngitis"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "sinusitis, post-nasal drip or nasal stuffiness"
                                        }
                                    ]
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "11", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "9", 
                                                "@subjects_at_risk": "100"
                                            }
                                        ], 
                                        "sub_title": "decrease in appetite"
                                    }
                                }, 
                                "title": "Metabolism and nutrition disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "16", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "12", 
                                                "@subjects_at_risk": "100"
                                            }
                                        ], 
                                        "sub_title": "muscle pain, stiffness, cramps, or ache"
                                    }
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "100"
                                            }
                                        ], 
                                        "sub_title": "migraine headaches"
                                    }
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "100"
                                            }
                                        ], 
                                        "sub_title": "mental depression"
                                    }
                                }, 
                                "title": "Psychiatric disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "dysuria or UTI"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "nocturia"
                                        }
                                    ]
                                }, 
                                "title": "Renal and urinary disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "Asthma symptoms"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "cough"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "14", 
                                                    "@subjects_at_risk": "100"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "17", 
                                                    "@subjects_at_risk": "100"
                                                }
                                            ], 
                                            "sub_title": "Upper Respiratory Infection"
                                        }
                                    ]
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "5", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "100"
                                            }
                                        ], 
                                        "sub_title": "skin rash"
                                    }
                                }, 
                                "title": "Skin and subcutaneous tissue disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "CTCAE_4.03", 
                    "frequency_threshold": "3"
                }, 
                "serious_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "100"
                                            }
                                        ], 
                                        "sub_title": "Total, serious adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "100"
                                            }
                                        ], 
                                        "sub_title": "Hypoglycemia - pharmacy error in preparing insulin"
                                    }
                                }, 
                                "title": "Endocrine disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "100"
                                            }
                                        ], 
                                        "sub_title": "Left lower quadrant pain and vomiting - admitted overnight"
                                    }
                                }, 
                                "title": "Gastrointestinal disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "CTCAE_4.03"
                }, 
                "time_frame": "6 months of randomized treatment"
            }
        }, 
        "completion_date": {
            "#text": "October 2011", 
            "@type": "Actual"
        }, 
        "condition": [
            "Diabetes Mellitus", 
            "Hypertension", 
            "Metabolic Disease", 
            "Obesity", 
            "Sleep Apnea Syndrome"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Diabetes Mellitus", 
                "Hypertension", 
                "Metabolic Diseases", 
                "Obesity", 
                "Sleep Apnea Syndromes"
            ]
        }, 
        "detailed_description": {
            "textblock": "Obesity is a condition affecting one-third of the adult U.S. population and is a major risk\n      factor for the development of Type 2 diabetes, hyperlipidemia, hypertension, and other\n      cardiovascular and respiratory disorders.  Individuals with the onset of obesity during\n      childhood or adolescence are at increased risk for obesity-related, comorbid conditions,\n      both during adolescence and later in life.  African American girls and women are at\n      particular risk for obesity, and have substantial rates of obesity-related morbidity and\n      mortality.  Further, African American adult women have a less satisfactory response to many\n      therapeutic approaches used to treat obesity.  At present, there are no medical therapies\n      proven effective for the amelioration of severe obesity in children or adolescents.  One\n      medication that may have a favorable risk-benefit ratio in pediatric populations is orlistat\n      (Xenical(Trademark), Hoffmann LaRoche).  Orlistat acts by inhibiting gastrointestinal\n      lipases, interfering with the absorption of approximately 1/3 of ingested dietary fat.\n      Orlistat appears to be effective for reducing weight and obesity-associated comorbidities in\n      obese adults.  We propose to determine the safety, tolerability, and efficacy of orlistat in\n      12-17 year-old severely obese African American and Caucasian children and adolescents who\n      have one or more obesity-related comorbidity (hypertension, hyperlipidemia, sleep apnea,\n      hepatic steatosis, insulin-resistance, impaired glucose tolerance, or Type 2 diabetes).\n      Under this protocol, we have conducted an open-label pilot study of orlistat in twenty\n      subjects, suggesting orlistat has a similar side effect profile in adolescents as in adults.\n       We wish to determine the safety and efficacy of orlistat in reducing obesity-related\n      comorbidities using a randomized, double-blind, placebo-controlled clinical trial.  All\n      study participants will be enrolled in a psycho-educational weight loss program that\n      includes nutrition education, cognitive-behavioral self-monitoring strategies, and promotion\n      of physical activity.  We will also study the effects of orlistat on fat preferences, and\n      study the influence of genetic variables on energy expenditure and weight loss during\n      treatment.  A group of healthy, non-overweight children and adolescents will complete\n      questionnaires and exercise studies as a control group for interpretation of results in\n      overweight children and adolescents, but will not undergo phlebotomy or receive any\n      medication."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  INCLUSION CRITERIA:\n\n        Good general health.  Individuals taking medications for obesity-related comorbid\n        conditions will not be excluded.\n\n        Obesity:  body mass index for age and triceps skinfold above the 95th percentile\n        (determined by NHANES I age-, sex-, and race- specific data).  All subjects will be\n        required to be over 60 kg in body weight.\n\n        Evidence for a quantifiable obesity-related comorbidity.  Examples include:  systolic or\n        diastolic hypertension (determined by age-specific charts); frank Type 2 diabetes,\n        impaired glucose tolerance assessed by oral glucose tolerance testing; hyperinsulinemia\n        (defined as a fasting insulin greater than 15 mIU/mL); significant hyperlipidemia (total\n        cholesterol greater than 200 mg/dL, LDL cholesterol greater than 129 mg/dL or fasting\n        triglycerides greater than 200 mg/dL); hepatic steatosis (SGPT or SGOT above normal range\n        with negative hepatitis studies) or sleep apnea documented by a sleep study.\n\n        Age 12 to 17 years at the start of the study.\n\n        For girls with childbearing potential, a negative pregnancy test before taking and while\n        taking study medication.  Sexually active females must be using an effective form of birth\n        control.  These methods include total abstinence (no sex), oral contraceptives (\"the\n        pill\"), an intrauterine device (IUD), levonogestrol implants (Norplant), or\n        medroxyprogesterone acetate injections (Depo-provera shots).  If one of these cannot be\n        used, contraceptive foam with a condom is recommended.\n\n        Race of all four grandparents self-identified as either all Caucasian or all African\n        American.\n\n        EXCLUSION CRITERIA:\n\n        Volunteers will be excluded (and referred to non-experimental treatment programs) for the\n        following reasons:\n\n        Presence of renal, hepatic (other than obesity-related steatosis), gastrointestinal, most\n        endocrinologic (e.g., Cushing syndrome), or pulmonary disorders (other than either asthma\n        not requiring continuous medication or sleep apnea-related disorders);\n\n        Adolescent girls who are pregnant, who are currently nursing an infant, or who are having\n        unprotected intercourse;\n\n        Individuals who have, or whose parent or guardians have, current substance abuse or a\n        psychiatric disorder or other condition which, in the opinion of the investigators, would\n        impede competence or compliance or possibly hinder completion of the study;\n\n        Subjects who regularly use prescription medications unrelated to the complications of\n        obesity.  Oral contraceptive use will be permitted, provided the contraceptive has been\n        used for at least two months before starting study medication.  The use of\n        over-the-counter and prescription medications will be reviewed on a case-by-case basis;\n        depending on the medication, subjects who have continued to take prescription medication\n        for at least 3 months prior to study entry may be eligible;\n\n        Recent use (within six months) of anorexiant medications for the purpose of weight\n        reduction;\n\n        Inability to undergo MRI (e.g., volunteers with metal within their bodies including\n        cardiac pacemakers, neural pacemakers, aneurysmal clips, shrapnel, ocular foreign bodies,\n        cochlear implants, non-detachable electronic or electromechanical devices such as infusion\n        pumps, nerve stimulators, bone growth stimulators, etc. that are contraindications).\n\n        For pilot study participants, hypersensitivity or allergy to methylene blue.  Individuals\n        with documented G6PD deficiency will be excluded.\n\n        INCLUSION CRITERIA: HEALTHY CONTROL CHILDREN AND ADOLESCENTS:\n\n        Volunteers will qualify for inclusion if they meet the following criteria:\n\n          1. Good general health.\n\n          2. Age 12-17 years at study entry.\n\n          3. Body mass index (BMI) for age above the 5th percentile and below 85th percentile,\n             which is considered normal weight by CDC growth chart standards.\n\n          4. For females with childbearing potential, a negative pregnancy test at initial\n             evaluation.\n\n          5. Race of all four grandparents self-identified as either all Caucasian or all African\n             American.\n\n        EXCLUSION CRITERIA: HEALTHY CONTROL CHILDREN AND ADOLESCENTS:\n\n        Volunteers will be excluded for the following reasons:\n\n          1. Presence of past or present medical problems which would impair performance during\n             the exercise tests;\n\n          2. Females who are pregnant, or who are currently nursing an infant;\n\n          3. Individuals who have, or whose parent or guardian has, current substance abuse or a\n             psychiatric disorder or other condition that in the opinion of the investigators\n             would impede competence or possibly hinder completion of the study;\n\n          4. Recent weight change of more than 3% of body weight in the past two months;\n\n          5. Recent use (within six months) of anorexiant medications for the purpose of weight\n             reduction;\n\n          6. Physical impairments that would prevent completion of either the walk/run test or the\n             cycle test."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "17 Years", 
            "minimum_age": "12 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 3, 1999", 
        "firstreceived_results_date": "October 11, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00001723", 
            "org_study_id": "980111", 
            "secondary_id": "98-CH-0111"
        }, 
        "intervention": [
            {
                "arm_group_label": "Orlistat", 
                "description": "Subjects receive drug for 6 months plus a 12 week intensive behavioral weight los program. Subjects return for monthly visits for 3 more months.", 
                "intervention_name": "Orlistat", 
                "intervention_type": "Drug", 
                "other_name": "Xenical (orlistat)capsules"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Subjects receive drug for 6 months plus a 12 week intensive behavioral weight los program. Subjects return for monthly visits for 3 more months.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "Placebo capsule"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Orlistat"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Dyslipidemia", 
            "Race", 
            "Body Fat", 
            "Visceral Fat", 
            "Sleep Apnea", 
            "Fat-Soluble Vitamins", 
            "Type 2 Diabetes", 
            "Obesity", 
            "Childhood Obesity"
        ], 
        "lastchanged_date": "November 15, 2012", 
        "link": {
            "description": "NIH Clinical Center Detailed Web Page", 
            "url": "http://clinicalstudies.info.nih.gov/cgi/detail.cgi?B_1998-CH-0111.html"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Bethesda", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20892"
                }, 
                "name": "National Institutes of Health Clinical Center, 9000 Rockville Pike"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Safety and Efficacy of Orlistat (Xenical, Hoffmann LaRoche) in African American and Caucasian Children and Adolescents With Obesity-Related Comorbid Conditions", 
        "overall_official": {
            "affiliation": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", 
            "last_name": "Jack A Yanovski, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United States: Federal Government", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Body Mass index standard deviation score calculated for age and sex according to Centers for Disease Control standards. See:  Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 2002; (246): 1-190.", 
            "measure": "Change in BMI Standard Deviation Score", 
            "safety_issue": "No", 
            "time_frame": "baseline to 6 months"
        }, 
        "reference": [
            {
                "PMID": "8022039", 
                "citation": "Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA. 1994 Jul 20;272(3):205-11."
            }, 
            {
                "PMID": "7627244", 
                "citation": "Drent ML, Larsson I, William-Olsson T, Quaade F, Czubayko F, von Bergmann K, Strobel W, Sjostrom L, van der Veen EA. Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study. Int J Obes Relat Metab Disord. 1995 Apr;19(4):221-6."
            }, 
            {
                "PMID": "1406836", 
                "citation": "Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med. 1992 Nov 5;327(19):1350-5."
            }, 
            {
                "PMID": "15956632", 
                "citation": "Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA. 2005 Jun 15;293(23):2873-83. Erratum in: JAMA. 2005 Sep 28;294(12):1491."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001723"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", 
            "investigator_full_name": "Jack Yanovski", 
            "investigator_title": "Section Chief, Section on Growth and Obesity, PDEGEN, NICHD", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "results_reference": [
            {
                "PMID": "15112907", 
                "citation": "McDuffie JR, Calis KA, Uwaifo GI, Sebring NG, Fallon EM, Frazer TE, Van Hubbard S, Yanovski JA. Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions. J Pediatr Endocrinol Metab. 2004 Mar;17(3):307-19."
            }, 
            {
                "PMID": "12126214", 
                "citation": "McDuffie JR, Calis KA, Booth SL, Uwaifo GI, Yanovski JA. Effects of orlistat on fat-soluble vitamins in obese adolescents. Pharmacotherapy. 2002 Jul;22(7):814-22."
            }, 
            {
                "PMID": "12105286", 
                "citation": "McDuffie JR, Calis KA, Uwaifo GI, Sebring NG, Fallon EM, Hubbard VS, Yanovski JA. Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions. Obes Res. 2002 Jul;10(7):642-50."
            }
        ], 
        "secondary_outcome": [
            {
                "description": "Weight in kg", 
                "measure": "Change in Body Weight", 
                "safety_issue": "No", 
                "time_frame": "baseline to 6 months"
            }, 
            {
                "description": "BMI is calculated in kg/m2.  Change from baseline to 6 months of treatment", 
                "measure": "Change in Body Mass Index", 
                "safety_issue": "No", 
                "time_frame": "baseline to 6 months"
            }, 
            {
                "description": "body fat distribution measures obtained from Dual-energy X-ray Absorptiometry (DEXA)", 
                "measure": "Change in Body Fat (kg)", 
                "safety_issue": "No", 
                "time_frame": "baseline to 6 months"
            }, 
            {
                "description": "Difference in change of weight in kg according to race (Non-Hispanic White versus Non-Hispanic Black)", 
                "measure": "Effect of Race on Change in Weight (kg)", 
                "safety_issue": "No", 
                "time_frame": "baseline to 6 months"
            }
        ], 
        "source": "National Institutes of Health Clinical Center (CC)", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", 
                    "agency_class": "NIH"
                }, 
                {
                    "agency": "Roche Pharma AG", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "Jack Yanovski", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "May 1998", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }, 
    "geocoordinates": {
        "National Institutes of Health Clinical Center, 9000 Rockville Pike": "38.985 -77.095"
    }
}